Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Current Pharmaceutical Design|March 9, 2010
Pharmacogenetics of thiopurines in inflammatory bowel diseaseLuc J J Derijks, Dennis R WongClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 25, 2006
Pharmacogenomics in inflammatory bowel diseaseLaurence J Egan, Luc J J Derijks, Daniel W HommesEuropean Journal of Gastroenterology & Hepatology|January 9, 2015
Therapeutic drug monitoring of infliximab in inflammatory bowel disease patients in a teaching hospital setting: results of a prospective cohort studyAndrea Warman, Jan Willem A Straathof, Luc J J DerijksEuropean Journal of Drug Metabolism and Pharmacokinetics|July 31, 2025
Simulated Dosing Regimens of Subcutaneous Infliximab in Adults and Children with Inflammatory Bowel Disease: Exploring Switch and Initiation StrategiesRianne A Weersink, Ron J Keizer, Luc J J DerijksTherapeutic Drug Monitoring|August 29, 2025
Therapeutic Drug Monitoring and Pharmacogenomics of Thiopurines in Inflammatory Bowel Disease: International Guidelines RevisitedAhmed B Bayoumy, Luc J J Derijks, Nanne K H de BoerClinical Pharmacokinetics|March 8, 2018
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel DiseaseLuc J J Derijks, Dennis R Wong, Daniel W Hommes, et al.Pharmaceutics|January 8, 2025
The Use of Tissue Concentrations of Biological and Small-Molecule Therapies in Clinical Studies of Inflammatory Bowel DiseasesAhmed B Bayoumy, Luc J J Derijks, Bas Oldenburg, et al.International Journal of Clinical Pharmacy|November 30, 2012
Pharmacokinetics of midazolam in resuscitated patients treated with moderate hypothermiaDiane E T Bastiaans, Eleonora L Swart, Jesse P van Akkeren, et al.Nederlands Tijdschrift Voor Geneeskunde|October 30, 2010
[Guideline 'Diagnosis and treatment of inflammatory bowel disease in adults'. II. Special situations and organisation of medical care]Gerard Dijkstra, Luc J J Derijks, Govert J Houwert, et al.Frontiers in Microbiology|March 13, 2023
Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel diseaseHeike E F Becker, Karlijn Demers, Luc J J Derijks, et al.Pageof 5